Anxiety and cognition are associated with dopaminergic dysfunction in de novo Parkinson’s disease
Objective: To explore the relationships between nigrostriatal dysfunction and both neuropsychiatric (including anxiety, depression and apathy) and cognitive symptoms in newly diagnosed, drug-naive Parkinson's disease…Neuropsychological safety of bilateral pallidal (GPi) deep brain stimulation (DBS) for Parkinson’s disease (PD) under general anesthesia
Objective: To evaluate neuropsychological outcome of bilateral GPi DBS carried out under general anesthesia using a combination of direct anatomical targeting and intraoperative computed tomography…Screening for neuropsychiatric symptoms in Parkinson’s disease
Objective: To determine the convergent validity of the screening questions included in instructions to patients for Part 1A of the International Parkinson and Movement Disorder…Suggested protocol for electroconvulsive therapy for depression in a Parkinson’s disease patient with a deep brain stimulator: A case report
Objective: To report an evidence for safety of ECT in patients with DBS in place. Background: We report a case of bilateral electroconvulsive therapy (ECT)…Anxiety and parkinsonism signs in idiopathic REM sleep behavior disorder
Objective: To explore the relationship between parkinsonism signs and anxiety symptoms in patients with idiopathic REM sleep behavior disorder (iRBD). Background: A recent study reported…Cognitive impairment in Parkinson’s disease
Objective: To study features of cognitive symptoms in PD, depending on the severity of the disease. Background: Parkinson's disease (PD) is shown a wide range…The dopamine agonist withdrawal syndrome rating scale (DAWS-RS): Initial development of a new non-motor scale
Objective: To describe the development of the dopamine agonist withdrawal syndrome (DAWS) rating scale (DAWS-RS), a new questionnaire designed to evaluate the symptoms, severity, and…Cervical dystonia and quality of life
Objective: To evaluate appearance of depression and anxiety in patiens with cervical dystonia and influence of dystonia symptoms on the quality of life. Background: Cervical…The effects of fluvoxamine maleate in a post-natal stress rat model of neurodegeneration
Objective: In this study, we investigated whether treatment of anxiety-like symptoms with Fluvoxamine maleate alleviates the neurotoxic effects of 6-OHDA in a Parkinsonian rat model.…The effect of improved nutritional status on psychiatric features and quality of life in Parkinson’s disease patients
Objective: To determine the effect of nutritional status in 6 weeks time on depression, anxiety and quality of life in Parkinson's disease (PD) patients. Background:…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.